Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Hagiwara M, Delea TE, Stanford RH. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations. Allergy and Asthma Proceedings 2014; 35(1): 54-62 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adrenergic beta-2 Receptor Agonists /administration & Albuterol /administration & Androstadienes /administration & Anti-Allergic Agents /administration & Asthma /drug therapy /economics; Drug Therapy, Combination; Female; Fluticasone; Health Care Costs; Humans; Male; Patient Compliance; Retrospective Studies; Salmeterol Xinafoate; Treatment Outcome; Young Adult; derivatives /economics /therapeutic use; dosage /analogs & dosage /economics /therapeutic use; dosage /economics /therapeutic use; dosage /economics /therapeutic use AccessionNumber 22014010032 Date bibliographic record published 29/04/2014 |